logo-loader
viewKromek Group PLC

Kromek jumps on award of DARPA contract extension

The new deal, worth up to US$5.2mln, will see Kromek perform further work on its mobile wide-area bio-surveillance system capable of detecting airborne pathogens

Kromek Group PLC - Kromek awarded DARPA contract extension to develop pathogen identification technology

Kromek Group PLC (LON:KMK) said it has been awarded an extension to its contract with the Defense Advanced Research Projects Agency (DARPA) to detect and identify pathogens in an urban environment.

The detection technology specialist said under the new deal it will be awarded up to US$5.2mln to further work on its mobile wide-area bio-surveillance system capable of detecting airborne pathogens.

READ: Kromek updates on business and response to coronavirus pandemic

The extension follows completion of the base period of the DARPA contract which was awarded in December 2018 to develop a vehicle-mounted biological threat identifier.

Kromek said the miniaturised system will be capable of detecting viruses and bacteria and is intended to be located on vehicles to detect the presence of a pathogenic threat. The small, unmanned system will run all day and be used in high footfall areas such as hospitals and airports.

The total contract period will run until June 2021, with the completed system aiming to expand the existing SIGMA network for biological threats as part of DARPA's SIGMA+ initiative.

"We are delighted to be awarded this extension by DARPA. The technology developed under this program is capable of sample collection to comprehensive analysis of threats present in air in an autonomous manner. By sequencing the genetic code, the device can not only identify threat pathogens, but also be used to identify the particular strain to aid triage and treatment selection, in addition to being able to track mutations of the pathogen”, Kromek chief executive Arnab Basu said in a statement.

"As the system can be vehicle-mounted or placed in high footfall areas such as hospitals and airports, the location where the sample is collected can be mapped to a GPS position. The transfer of data to a central server allows a picture of pathogen levels across a city to be built up enabling decision-makers to react rapidly to any evolving pathogenic threat", he added.

The shares jumped 9.9% to 22.2p in early deals on Wednesday.

--Adds share price--

Quick facts: Kromek Group PLC

Price: 16.9 GBX

AIM:KMK
Market: AIM
Market Cap: £58.24 m
Follow

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Kromek Group PLC named herein, including the promotion by the Company of Kromek Group PLC in any Content on the Site, the Company receives from...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Kromek Group CEO details DARPA extension and 'groundbreaking' pathogen...

Kromek Group PLC's (LON:KMK) Dr Arnab Basu speaks to Proactive London's Andrew Scott after reporting they've been awarded an extension to its contract with the Defense Advanced Research Projects Agency (DARPA) to detect and identify pathogens in an urban environment. Under the deal it will be...

on 27/5/20

2 min read